[Chronic aggressive hepatitis B: effectiveness of the control of immunosuppressive therapy. Value of biopsy and laboratory chemical procedures].
J
J
Ohlen
H
H
Selmair
D000118:Acetylglucosaminidase / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D001706:Biopsy; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008099:Liver / Q000473:pathology; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism; D011239:Prednisolone / Q000627:therapeutic use*; D011347:Procollagen / Q000378:metabolism
D007074:Immunoglobulin G; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D011239:Prednisolone; D000118:Acetylglucosaminidase; D001379:Azathioprine
Chronisch-aggressive Hepatitis B: Effektivitätskontrolle einer immunsuppressiven Therapie. Die Aussagekraft bioptischer und laborchemischer Verfahren.